Details for: NEULASTA
Company: AMGEN CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02249790 | NEULASTA | PEGFILGRASTIM | 10 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.